NCT02198157

Brief Summary

  • Labor is divided into three stages: the first stage is from labor onset until full dilation, second stage is from full dilation until delivery of the baby, and the third stage from the delivery of the baby until the delivery of the placenta
  • The mean duration of second stage in nulliparas as defined by the American college of obstetricians and gynecologists (ACOG) is 54 minutes
  • Epidural anesthesia is a known cause for prolongation of the second stage of labor. Prolonged second stage in nullipara women with epidural is defined as more than 3 hours, and more than 2 hours in those without epidural.
  • Although perinatal outcome is not compromised with a prolonged second stage , there is evidence that maternal morbidities such as perineal trauma, chorioamnionitis ,instrumental delivery and postpartum hemorrhage increase with prolonged second stage
  • Another effect of epidural anesthesia during labor is urinary retention and a need for catheterization.
  • Full bladder may behave as a tumor previa and interfere to fetal head descent in the birth canal, increasing by that the duration of the second stage.
  • This study aims to investigate the effect of intermittent versus continuous catheterization on the duration of the second stage of labor

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

July 21, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 23, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

February 23, 2016

Status Verified

February 1, 2016

Enrollment Period

10 months

First QC Date

July 21, 2014

Last Update Submit

February 20, 2016

Conditions

Keywords

duration of second stageurinary catheterizationepidural anaesthesia

Outcome Measures

Primary Outcomes (1)

  • duration of second stage of labor

    within the first 48 hours after delivery

Secondary Outcomes (1)

  • chorioamnionitis

    within the first 48 hours after delivery

Other Outcomes (1)

  • post-partum hemorrhage

    within the first 48 hours after delivery

Study Arms (2)

intermittent urinary catheterization

ACTIVE COMPARATOR

nullipara women with epidural anaesthesia who pose urination difficulty will receive intermittent catheterization

Other: urinary catheterization

continuous urinary catheter

ACTIVE COMPARATOR

nullipara women with epidural anaesthesia who pose urination difficulty will receive continuous catheterization

Other: urinary catheterization

Interventions

nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.

Also known as: continuous versus intermittent catheterization.
continuous urinary catheterintermittent urinary catheterization

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Nulliparous women
  • Gestational age 24-42 weeks
  • epidural anaesthesia
  • Vertex presentation
  • Singleton

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. OB/GYN, HaEmek Medical Center

Afula, Israel

Location

MeSH Terms

Interventions

Urinary Catheterization

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, UrologicalDiagnostic Techniques and ProceduresDiagnosisCatheterizationTherapeuticsInvestigative Techniques

Study Officials

  • raed salim, MD

    Dep. OB/GYN, HaEmek Medical Center, Afula, Israel

    STUDY DIRECTOR
  • abeer suleiman, MD

    Dep. OB/GYN, HaEmek Medical Center, Afula, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 21, 2014

First Posted

July 23, 2014

Study Start

July 1, 2014

Primary Completion

May 1, 2015

Study Completion

July 1, 2015

Last Updated

February 23, 2016

Record last verified: 2016-02

Locations